These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 941300)

  • 1. The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.
    Dreisin RB; Scoggin C; Davidson PT
    Tubercle; 1976 Mar; 57(1):49-57. PubMed ID: 941300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapidly growing mycobacteria--Mycobacterium fortuitum and Mycobacterium chelonei.
    Brown TH
    Infect Control; 1985 Jul; 6(7):283-8. PubMed ID: 3891655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M. fortuitum and M. chelonei-fast growing mycobacteria. A review with a case report.
    Ward JM
    Br J Dermatol; 1975 Apr; 92(4):453-9. PubMed ID: 1156561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanently successful chemotherapy in two cases with severe pulmonary mycobacterial disease due to Mycobacterium kansasii and fortuitum, respectively.
    Radenbach KL
    Scand J Respir Dis Suppl; 1972; 80():23-7. PubMed ID: 4510913
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed hypersensitivity reactions in patients with Mycobacterium chelonei and Mycobacterium fortuitum infections.
    Hoffman PC; Fraser DW; Hinson PL
    Am Rev Respir Dis; 1978 Mar; 117(3):527-31. PubMed ID: 629486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin.
    Jadeja L; Bolivar R; Wallace RJ; Silcox VA; Bodey GP
    Ann Intern Med; 1983 Oct; 99(4):475-7. PubMed ID: 6625380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial isolations in young adults with cystic fibrosis.
    Smith MJ; Efthimiou J; Hodson ME; Batten JC
    Thorax; 1984 May; 39(5):369-75. PubMed ID: 6429879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
    Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR; Pankey GA
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of disease due to rapidly growing mycobacteria.
    Wallace RJ; Swenson JM; Silcox VA; Good RC; Tschen JA; Stone MS
    Rev Infect Dis; 1983; 5(4):657-79. PubMed ID: 6353528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium szulgai; a new pathogen causing infection of the lung.
    Davidson PT
    Chest; 1976 Jun; 69(6):799-801. PubMed ID: 1277906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
    Apiwattankul N; Flynn PM; Hayden RT; Adderson EE
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):104-13. PubMed ID: 26407409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium fortuitum mastoiditis.
    Austin WK; Lockey MW
    Arch Otolaryngol; 1976 Sep; 102(9):558-60. PubMed ID: 962700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.